US equities
|
SPCX
$168.70
▲+6.13%
NVDA
$237.51
▲+1.52%
MU
$1,065.38
▼-0.88%
TSLA
$380.34
▲+2.63%
MSFT
$524.63
▲+1.37%
SNDK
$1,714.46
▼-0.32%
INTC
$116.82
▼-2.10%
META
$744.05
▲+2.19%
SPCX
$168.70
▲+6.13%
NVDA
$237.51
▲+1.52%
MU
$1,065.38
▼-0.88%
TSLA
$380.34
▲+2.63%
MSFT
$524.63
▲+1.37%
SNDK
$1,714.46
▼-0.32%
INTC
$116.82
▼-2.10%
META
$744.05
▲+2.19%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Sotera Health Company - Common Stock
(NQ:
SHC
)
18.55
+0.34 (+1.84%)
Delayed Quote
Updated: 1:41 PM EDT, Oct 5, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Sotera Health Company - Common Stock
< Previous
1
2
...
6
7
8
9
10
11
12
13
Next >
Sotera Health Company (SHC) Q3 2021 Earnings Call Transcript
↗
November 11, 2021
SHC earnings call for the period ending September 30, 2021.
Via
The Motley Fool
Topics
Earnings
Why Sotera Health Stock Is Falling Today
↗
November 10, 2021
Investors weren't happy with the company's full-year guidance.
Via
The Motley Fool
The Daily Biotech Pulse: Valneva Inks COVID-19 Vaccine Supply Contract In Europe, I-Mab Spikes On China Deal, DermTech Sinks On Guidance
↗
November 10, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus MorphoSys COO To Leave To Pursue Other Opportunities MorphoSys AG (NASDAQ:...
Via
Benzinga
The Week Ahead In Biotech (Nov. 7-Nov. 13): Earnings Taper Off, Multiple Conference Presentations, IPOs And More
↗
November 08, 2021
Biotech stocks reversed course and closed the week ended Nov. 5 lower, squandering the gains notched early in the week. What was good news for Pfizer, Inc. (NYSE: PFE) turned out...
Via
Benzinga
Sotera Health Company (SHC) Q2 2021 Earnings Call Transcript
↗
August 12, 2021
SHC earnings call for the period ending June 30, 2021.
Via
The Motley Fool
Topics
Earnings
Earnings Scheduled For August 12, 2021
↗
August 12, 2021
Companies Reporting Before The Bell • Anavex Life Sciences (NASDAQ:AVXL) is estimated to report earnings for its third quarter. • ITeos Therapeutics (NASDAQ:ITOS...
Via
Benzinga
Sotera Health Company (SHC) Q1 2021 Earnings Call Transcript
↗
May 13, 2021
SHC earnings call for the period ending March 31, 2021.
Via
The Motley Fool
Topics
Earnings
Earnings Scheduled For May 13, 2021
↗
May 13, 2021
Companies Reporting Before The Bell • CASI Pharmaceuticals (NASDAQ:CASI) is estimated to report quarterly loss at $0.06 per share on revenue of $5.05 million. •...
Via
Benzinga
The Daily Biotech Pulse: Split Verdict For Chemocentryx, NKarta-CRISPR In Cell Therapy Collaboration, Orphazyme's Clinical Trial Setback, 2 IPOs
↗
May 07, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 6) GT Biopharma, Inc. (NASDAQ:...
Via
Benzinga
< Previous
1
2
...
6
7
8
9
10
11
12
13
Next >
